124 10. Haberland C, Brunngraber EG, Witting LA, Hof H (1972) Late infantile amaurotic idiocy (LIAI). Anatomochemical report of a case. Neurology 22:305–311 11. Hartikainen JM, Ju W, Wisniewski KE, Moroziewicz DN, Kacz- marski AL, McLendon L, Zhong D, Suarez CT, Brown WT, Zhong N (1999) Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Mol Genet Metab 67:162–168 12. Ju W, Zhong R, Moore S, Moroziewicz D, Currie JR, Parfrey P, Brown WT, Zhong N (2002) IdentiWcation of novel CLN2 muta- tions shows Canadian speciWc NCL2 alleles. J Med Genet 39:822– 825 13. Kyttala A, Lahtinen U, Braulke T, Hofmann SL (2006) Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Bio- chim Biophys Acta 1762:920–933 14. Lin L, Lobel P (2001) Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations. Hum Mutat 18:165 15. Mole SE (2004) The genetic spectrum of human neuronal ceroid- lipofuscinoses. Brain Pathol 14:70–76 16. Ramadan H, Al-Din AS, Ismail A, Balen F, Varma A, Twomey A, Watts R, Jackson M, Anderson G, Green E, Mole SE (2007) Adult neuronal ceroid lipofuscinosis caused by deWciency in palmitoyl protein thioesterase 1. Neurology 68:387–388 17. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maeh- len J, Lehesjoki AE, Tyynela J (2006) Cathepsin D deWciency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129:1438–1445 18. Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P (1997) Association of mutations in a lysosomal pro- tein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277:1802–1805 19. Steinfeld R, Heim P, von Gregory H, Meyer K, Ullrich K, Goebel HH, Kohlschutter A (2002) Late infantile neuronal ceroid lipofus- cinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 112:347–354 Acta Neuropathol (2008) 116:119–124 20. Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, Gartner J (2006) Cathepsin D deWciency is associated with a human neurodegenerative disorder. Am J Hum Genet 78:988–998 21. Tyynela J, Cooper JD, Khan MN, Shemilts SJ, Haltia M (2004) Hippocampal pathology in the human neuronal ceroid-lipofusci- noses: distinct patterns of storage deposition, neurodegeneration and glial activation. Brain Pathol 14:349–357 22. van Diggelen OP, Thobois S, Tilikete C, Zabot MT, Keulemans JL, van Bunderen PA, Taschner PE, Losekoot M, Voznyi YV (2001) Adult neuronal ceroid lipofuscinosis with palmitoyl- protein thioesterase deWciency: Wrst adult-onset patients of a child- hood disease. Ann Neurol 50:269–272 23. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipo- fuscinosis. Nature 376:584–587 24. Williams RE (1999) CLN2, Classic Late Infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The Neuronal Ceroid Lipofuscinoses (Batten Disease). IOS Press, Amsterdam, pp 37–40 25. Wisniewski KE, Kaczmarski A, Kida E, Connell F, Kaczmarski W, Michalewski MP, Moroziewicz DN, Zhong N (1999) Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 66:248–252 26. Wisniewski KE, Kida E, Golabek AA, Kaczmarski W, Connel F, Zhong N (2001) Neuronal Ceroid Lipofuscinoses: ClassiWcation and Diagnosis.In Advances in Genetics. Academic Press, New York, pp 1–30 27. Wlodawer A, Durell SR, Li M, Oyama H, Oda K, Dunn BM (2003) A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine- carboxyl peptidases. BMC Struct Biol 3:8 28. Young EP, Worthington VC, Jackson M, Winchester BG (2001) Pre-and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities. Eur J Paediatr Neurol 5(Suppl A):193–196 123